The anti-smoking foundation Cliff Douglas heads was funded by Philip Morris International, though he negotiated a split from the company.May 13, 2024Check out STAT+Sponsored By Sylvia Jarrus for STAT After decades fighting Big Tobacco, Cliff Douglas now leads a foundation funded by his former adversaries The anti-smoking foundation Douglas heads was funded by Philip Morris International, though he negotiated a split from the cigarette company. By Nicholas Florko CDC launching wastewater dashboard to track bird flu virus spread Testing wastewater from 600 sites nationally for influenza A virus could provide communities early warning of possible bird flu outbreaks. By Megan Molteni and Helen Branswell STAT+ | Can AI build custom 'n-of-1' drugs faster? Maybe not yet, new case study suggests Advocates and biotech executives hope that AI can help speed a wave of custom medicines. A new study suggests that outcome may still be years away. By Jason Mast Molly Ferguson for STAT STAT+ | FDA is criticized for taking a 'ministerial' role in sorting out some pharma patents The agency "needs to show some leadership ... but instead, they have been flip-flopping for years," said Tahir Amin of the nonprofit I-MAK. By Ed Silverman STAT+ | Late-stage results set up Cytokinetics heart drug to compete with Bristol Overall, the results suggest aficamten could be used more flexibly than Camzyos while delivering similar levels of efficacy and safety. By Elaine Chen Melinda French Gates resigns as Gates Foundation co-chair Melinda French Gates announced she will step down as co-chair of the philanthropy she built with ex-husband Bill Gates. By Associated Press YUKI IWAMURA/AFP via Getty Images Opinion: Congress: Close Medicare's dangerous gaps in coverage for addiction treatment Medicare does not cover key addiction care services. That costs lives, is discriminatory, and needs to change. By Brian Hurley and Paul N. Samuels STAT+ | Sandoz disavows U.K. trade group over dispute about promoting a biosimilar for multiple sclerosis At issue was an anonymous complaint filed in May 2023 by a physician who contended that Sandoz unfairly attempted to promote its medicine. By Ed Silverman More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2024, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments